paroxetine has been researched along with Sleep Wake Disorders in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kantor, S; Kulkarni, S; Morton, AJ; Varga, J | 1 |
| Bhaskar, S; Joffe, H; Kazempour, K; Lippman, J; Mekonnen, H; Pinkerton, JV | 1 |
| Beeské, S; Belzung, C; Griebel, G; Philbert, J | 1 |
| Aloisi, A; Angioli, R; Capriglione, S; Lopez, S; Luvero, D; Montera, R; Plotti, F; Scaletta, G; Serra, GB | 1 |
| Cui, H; Li, Y; Qiu, C; Tang, X; Zhang, W; Zhang, Y; Zhu, H | 1 |
| Dubois, O | 1 |
| Auerbach, S; Brass, SD | 1 |
| Imai, S; Kuzumaki, N; Narita, M; Rahmadi, M; Suzuki, T; Yamashita, A | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, GJ; Keller, MB; Porta, G; Ryan, N; Shamseddeen, W; Wagner, KD | 1 |
| Fiscella, K; Heckler, C; Innominato, PF; Janelsins, M; Kesler, S; Manber, R; Morrow, GR; Mustian, KM; Palesh, OG; Peppone, LJ; Roth, T; Sprod, LK | 1 |
| Kline, NA; Matloff, JL; Stein, MB | 1 |
| Greil, W; Wolfsperger, M | 1 |
| Andreescu, C; Cyranowski, JM; Dombrovski, AY; Houck, PR; Lenze, EJ; Mazumdar, S; Mulsant, BH; Reynolds, CF | 1 |
| Lillywhite, AR; Nutt, DJ; Wilson, SJ | 1 |
| Bell, CJ; Lillywhite, AR; Nutt, DJ; Potokar, JP; Wilson, SJ | 1 |
| Bell, C; Nutt, D | 1 |
| Azoulay, P; Septien, L; Waintraub, L | 1 |
| Jacobsen, PB; Minton, S; Moncello, J; Weitzner, MA | 1 |
1 review(s) available for paroxetine and Sleep Wake Disorders
| Article | Year |
|---|---|
[Indications for crenotherapy].
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Asthenia; Balneology; Complementary Therapies; Depressive Disorder; Humans; Mental Disorders; Multicenter Studies as Topic; Paroxetine; Randomized Controlled Trials as Topic; Sleep Wake Disorders; Somatoform Disorders | 2009 |
9 trial(s) available for paroxetine and Sleep Wake Disorders
| Article | Year |
|---|---|
Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.
Topics: Adult; Aged; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Placebos; Postmenopause; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Sleep; Sleep Wake Disorders | 2015 |
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
Topics: Adult; Aged; Double-Blind Method; Female; Genital Neoplasms, Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Survivors; Treatment Outcome | 2016 |
Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Drug Interactions; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sleep Wake Disorders; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Treatment Outcome; Young Adult | 2012 |
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.
Topics: Antipsychotic Agents; Benzodiazepines; Combat Disorders; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Paroxetine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Treatment Outcome | 2002 |
Residual symptoms and recurrence during maintenance treatment of late-life depression.
Topics: Affect; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Motivation; Paroxetine; Personality Inventory; Psychotherapy; Secondary Prevention; Sleep Wake Disorders; Treatment Outcome | 2007 |
Adult night terrors and paroxetine.
Topics: Adult; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders | 1997 |
Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Azabicyclo Compounds; Depressive Disorder; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Paroxetine; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Sleep Wake Disorders; Thiazepines | 2002 |
A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Depression; Fatigue; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders | 2002 |
8 other study(ies) available for paroxetine and Sleep Wake Disorders
| Article | Year |
|---|---|
Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.
Topics: Animals; Brain; Brain Waves; Huntington Disease; Male; Mice, Inbred C57BL; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Sleep Wake Disorders | 2017 |
The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.
Topics: Animals; Brain; Cycloserine; Disease Models, Animal; Electroencephalography; Electroshock; Hydrocarbons, Halogenated; Male; Mice; Paroxetine; Receptors, Corticotropin-Releasing Hormone; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Stress Disorders, Post-Traumatic; Stress, Psychological; Thiazines; Wakefulness | 2015 |
Characteristics of objective daytime sleep among individuals with earthquake-related posttraumatic stress disorder: A pilot community-based polysomnographic and multiple sleep latency test study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; China; Circadian Rhythm; Cross-Sectional Studies; Disasters; Earthquakes; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Polysomnography; Sleep; Sleep Wake Disorders; Stress Disorders, Post-Traumatic; Young Adult | 2017 |
A sleepy patient with REM rebound.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Humans; Male; Narcolepsy; Paroxetine; Polysomnography; Sleep Wake Disorders; Trazodone | 2009 |
Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milnacipran.
Topics: Animals; Brain; Cyclopropanes; Electroencephalography; Electromyography; Histamine; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Milnacipran; Neuropeptides; Orexin Receptors; Orexins; Paroxetine; Receptors, Histamine; Receptors, Neuropeptide; Reverse Transcriptase Polymerase Chain Reaction; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Synaptic Transmission | 2011 |
Galactorrhea during treatment with trimipramine. A case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Female; Galactorrhea; Humans; Paroxetine; Prolactin; Sleep Wake Disorders; Suicide, Attempted; Trimipramine | 2005 |
Successful treatment of night terrors and somnambulism with paroxetine.
Topics: Clonazepam; Drug Therapy, Combination; Female; Humans; Middle Aged; Paroxetine; Polysomnography; Sleep Wake Disorders; Somnambulism | 1994 |
Paroxetine and its uses in psychiatry.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Depression; Drug Interactions; Humans; Mental Disorders; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders | 1999 |